repaglinide (Novo Nordisk)
86
Structured Review
Novo Nordisk
repaglinide
Repaglinide, supplied by Novo Nordisk, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/repaglinide/repaglinide/10__34689_slash_sh__2025__27__3__004-95-13-15
Average 86 stars, based on 1 article reviews
Repaglinide, supplied by Novo Nordisk, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/repaglinide/repaglinide/10__34689_slash_sh__2025__27__3__004-95-13-15
Average 86 stars, based on 1 article reviews
repaglinide - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Produced:Article Title: Challenge of diabetes mellitus and researchers’ contributions to its control Article Snippet: .. In 1998, Control:Article Title: Towards FDA-USPTO Cooperation Article Snippet: Electronic copy available at: https://ssrn.com/abstract=5129604 Pr ep in t n t p er r vie we d The litigation in Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S suggests the possibilities for the strategic drafting of use codes given FDA policies.260 In that case, Novo Nordisk’s patent claimed the active ingredient of the drug PRANDIN (repaglinide) had expired.261 The USPTO had granted Novo Nordisk an additional patent claiming a method of using repaglinide in combination with metformin,262 while the FDA granted Novo Nordisk marketing approval for three uses of repaglinide to treat diabetes: repaglinide by itself; repaglinide in combination with thiazolidinediones (“TZDs”); and repaglinide in combination with metformin.263 As a result of these FDA and USPTO decisions, Novo Nordisk held marketing approval for three methods of using repaglinide, but only one of them, the combination therapy of repaglinide and metformin, remained patented. .. Novo Nordisk nonetheless presented to the FDA a use code narrative reciting a “method for improving glycemic control in adults with type 2 diabetes.”264 This expansive use code covered each of the three approved methods for using other:Article Title: THE EFFECT OF REPAGLINIDE AND METFORMIN ON EXTERNAL RESPIRATORY FUNCTION IN PATIENTS WITH DIABETES AND ISCHEMIC HEART DISEASE ASSOCIATED WITH OBESITY Article Snippet: They were divided into two groups of 30 people: some were treated with Article Title: Process of preparing guanylate cyclase C agonisys Article Snippet: No. 4,379,785, such as Amaryl, Aventis), glipentide, glipizide (e.g. Glucotrol or Glucotrol XL Extended Release, Pfizer), gliquidone, glisolamide, glyburide/glibenclamide (e.g. Micronase or Glynase Prestab, Pharmacia & Upjohn and Diabeta, Aventis), tolazamide (e.g. Tolinase), and tolbutamide (e.g. Orinase), and pharmaceutically acceptable salts and esters thereof; meglitinides such as Article Title: Ultra-pure agonists of guanylate cyclase C, method of making and using same Article Snippet: No. 4,379,785, such as Amaryl, Aventis), glipentide, glipizide (e.g. Glucotrol or Glucotrol XL Extended Release, Pfizer), gliquidone, glisolamide, glyburide/glibenclamide (e.g. Micronase or Glynase Prestab, Pharmacia & Upjohn and Diabeta, Aventis), tolazamide (e.g. Tolinase), and tolbutamide (e.g. Orinase), and pharmaceutically acceptable salts and esters thereof; meglitinides such as Article Title: Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials Article Snippet: VICTORIA NCT01761318 2019 The Netherlands Standard treatments 26 Placebo Metformin with or without 6 Novo Nordisk Study ID Registration Year Country Intervention N Drug Dose Cointervention Follow -up* Settings Fundings sulfonylurea and/or insulin Marbury 1999 Not applicable 1999 USA Meglitinides 383 Repaglinide 1.5-12 mg daily None or oral agents 12 |